Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2013
10/09/2013CN103347535A Liquid viral formulations
10/09/2013CN103347534A Bovine viral diarrhea virus type 1b vaccine compositions and methods
10/09/2013CN103347521A Methods of metabolic targeting cancer cells using che mo- and immunotherapy for treating cancer
10/09/2013CN103347514A FGFR1 extracellular domain combination therapies
10/09/2013CN103347494A Oral vaccine fast-dissolving dosage form using starch
10/09/2013CN103343102A Streptococcus suis serotype II htpsC gene knockout mutant strain and application thereof
10/09/2013CN103342751A Antibody neutralizers of human granulocyte macrophage colony stimulating factor
10/09/2013CN103342749A Triple egg yolk antibody against newcastle disease virus, avian influenza virus and infectious bronchitis virus
10/09/2013CN103341179A Mucosa M-cell targeted viral myocarditis gene vaccine and preparation method thereof
10/09/2013CN103341172A Dual-hole polysaccharide microspheres, preparation method and purpose thereof
10/09/2013CN103341168A Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer
10/09/2013CN103341164A Infectious bursal disease antigen-antibody complex as well as preparation and preparation method thereof
10/09/2013CN103341163A Double-effect horse antiserum used for rabies and tetanus and preparation method thereof
10/09/2013CN103341162A Freeze-dried vaccine of porcine transmissible gastroenteritis
10/09/2013CN103087156B Foot and mouth disease virus (FMDV) antigen polypeptide and vaccine
10/09/2013CN102628053B Construction and application of recombinant Chicken Marek's Disease Virus SC9-1 strain and SC9-2 strain
10/09/2013CN102533669B 鸭byd病毒灭活疫苗及其制备方法 Duck byd inactivated virus vaccines and preparation method
10/09/2013CN102499983B Application of HepG2.2.15 cell autophagy corpuscle in preparing hepatitis b virus (HBV) therapeutic vaccines
10/09/2013CN102380093B Method for producing newcastle disease living vaccines by utilizing passage fibroblasts
10/09/2013CN102296044B Unmarked gene-deleted and attenuated mutant strain of vibrio alginolyticus wild strain, and preparation and use thereof
10/09/2013CN102198264B Beta-defensin 15 of specific antibacterial peptides of rat epididymis and application thereof
10/09/2013CN102134279B Fusion protein and encoding gene thereof as well as application of fusion protein
10/09/2013CN102079783B Japanese blood fluke protein and application thereof
10/09/2013CN101724072B Sequence and application thereof of anti-tumor monoclonal antibody
10/09/2013CN101516396B Vaccine composition containing synthetic adjuvant
10/09/2013CN101437850B Anti-5T4 antibodies and uses thereof
10/08/2013US8552159 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
10/08/2013US8552157 c-Kit antibodies and uses thereof
10/08/2013US8552156 Anti-TIM-3 antibody
10/08/2013US8552154 Anti-PD-L1 antibodies and uses therefor
10/08/2013US8552145 Vaccine for modulating between T1 and T2 immune responses
10/08/2013US8551959 Glycolipid and use thereof
10/08/2013US8551953 Treatment of T-cell mediated diseases
10/08/2013US8551943 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
10/08/2013US8551699 PCA3, PCA3 genes, and methods of use
10/08/2013US8551696 Rubella E1 envelope protein variants and their use in detection of anti-rubella antibodies
10/08/2013US8551527 Process for stabilizing an adjuvant containing vaccine composition
10/08/2013US8551501 Chitin microparticles and their medical uses
10/08/2013US8551500 Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune response
10/08/2013US8551499 In vitro model of latent mycobacterial infection
10/08/2013US8551498 Solid composition containing Bacillus-type non-pathogenic bacterial spores
10/08/2013US8551497 Microbial vaccine and vaccine vector
10/08/2013US8551495 Anti-FMD vaccine composition and preparation and use thereof
10/08/2013US8551494 Methods of immune modulation with death receptor-induced apoptosis
10/08/2013US8551493 Peptide with reduced dimer formation
10/08/2013US8551492 Vaccine peptide combinations against cat allergy
10/08/2013US8551491 Processes for the preparation of a batch of an active pharmaceutical ingredient, a container comprising cryogranules of an allergen product, and a cryogranule of an allergen product
10/08/2013US8551490 Genetic products differentially expressed in tumors and use thereof
10/08/2013US8551489 Methods for the treatment of cancers
10/08/2013US8551488 Binding molecules for treatment and detection of cancer
10/08/2013US8551487 Methods for the treatment of IL-1β related conditions
10/08/2013US8551486 Monoclonal antibodies to human thymidine kinase to treat cancer
10/08/2013US8551485 Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells
10/08/2013US8551484 Human antibodies against hepatitis C virus (HCV) and uses thereof
10/08/2013US8551483 Methods of treating viral infections by administering KIR2DL-binding antibodies
10/08/2013US8551482 Compositions and methods for increasing muscle growth
10/08/2013US8551481 Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody
10/08/2013US8551479 Methods for treating melanoma
10/08/2013US8551478 Anti-CD3 antibodies and methods of use thereof
10/08/2013US8551477 Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same
10/08/2013US8551476 SP35 antibodies and uses thereof
10/08/2013US8551474 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
10/08/2013US8551451 Combination vaccine with acellular pertussis
10/08/2013CA2680222C Methods of treating ophthalmic diseases
10/08/2013CA2639074C Marked bovine viral diarrhea virus vaccines
10/08/2013CA2547459C Modulators of nik-siva complex formation for treating immune disorders
10/08/2013CA2512647C Method for manufacturing recombinant polyclonal proteins
10/08/2013CA2501939C Novel immunogenic proteins of leptospira
10/08/2013CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s)
10/08/2013CA2479304C Virus-like particles of human papillomavirus
10/08/2013CA2456007C Reduction in the virulence of mycobacterium tuberculosis and protection against tuberculosis by means of phop gene inactivation
10/08/2013CA2453403C Methods of inhibiting amyloid toxicity
10/08/2013CA2238893C Il-13 receptor polypeptide
10/04/2013CA2811762A1 Vaccine composition
10/03/2013WO2013149219A2 Fully human antibodies that bind to vegfr2
10/03/2013WO2013149194A1 Methods for treating hair loss disorders
10/03/2013WO2013149191A1 Methods for regulating hair growth disorders
10/03/2013WO2013149167A1 Lentiviral vector particles having improved transduction efficiency for cells expressing dc- sign
10/03/2013WO2013149058A1 Monoclonal antibodies specific to human cav-1 and uses thereof
10/03/2013WO2013149017A1 Vaccine adjuvant
10/03/2013WO2013148854A1 Anti-sema4d antibodies and epitopes
10/03/2013WO2013148686A2 Stable igg4 binding agent formulations
10/03/2013WO2013148427A1 Antigenic compositions and methods
10/03/2013WO2013148426A1 Microparticle vaccine against malaria
10/03/2013WO2013148405A2 Treatment for atherosclerosis
10/03/2013WO2013148327A1 Nipah virus envelope psuedotyped lentiviruses and methods of their use
10/03/2013WO2013148296A1 Antibodies to bradykinin b1 receptor ligands
10/03/2013WO2013148288A1 Diagnostic methods and compositions for treatment of cancer
10/03/2013WO2013148284A1 Antibodies that bind to a pcsk9 cleavage site and methods of use
10/03/2013WO2013148263A1 Anti-emp2 therapy reduces cancer stem cells
10/03/2013WO2013148258A1 Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
10/03/2013WO2013148248A1 Protease-regulated antibodies
10/03/2013WO2013148232A1 Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
10/03/2013WO2013148202A1 Novel compositions and methods for preventing or treating cancer metastasis
10/03/2013WO2013148164A1 Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
10/03/2013WO2013148159A1 Therapeutic methods for peritoneal carcinomatosis
10/03/2013WO2013147899A1 Osteoprotegerin derived composition and use thereof
10/03/2013WO2013147793A1 Methods and compositions for modulating notch activity
10/03/2013WO2013147642A1 Anti-tumour immunotherapy method
10/03/2013WO2013147628A2 Oral vaccine containing the bacillus subtilis spores and its application to immunise against helicobacter pylori
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 1823